StockNews.AI
CLOV
StockNews.AI
41 days

Clover Health Launches New Jersey Community Pharmacy Program in Partnership with IPC's iCare+ Network

1. Clover Health launched a pharmacy pilot program in New Jersey. 2. The program aims to improve medication management for seniors. 3. Partnership with IPC Digital Health enhances local pharmacy support. 4. Clover Assistant technology aids in monitoring medication adherence. 5. This initiative highlights Clover's commitment to local communities.

6m saved
Insight
Article

FAQ

Why Bullish?

Clover's new program demonstrates strong community engagement, improving member health outcomes. Historical initiatives improving local partnerships have previously benefited stock performance.

How important is it?

The article outlines a significant new initiative that could drive growth and enhance customer experience, directly impacting CLOV's market performance.

Why Long Term?

This program aligns with Clover's long-term strategy to enhance health services. Successful pilot expansion could drive sustained growth and brand loyalty.

Related Companies

July 09, 2025 08:30 ET  | Source: Clover Health Investments, Corp. WILMINGTON, Del., July 09, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a leading Medicare Advantage company committed to affordable, high-quality care, today announced the launch of a new community-based pharmacy pilot program across New Jersey. Built in partnership with IPC Digital Health™, a division of Independent Pharmacy Cooperative (IPC), this initiative is designed to help seniors better manage their medications and stay healthier at home, supported by the local pharmacies they know and trust. The program will be anchored by IPC’s iCare+™ Independent Pharmacy Network, which includes thousands of community-rooted pharmacies nationwide and many in New Jersey. These local pharmacies will deploy innovative care tools and virtual services that help Clover members with chronic conditions stay on track with their medications and avoid unnecessary hospital visits. “This is more than a new program—it’s a new model for how we support our New Jersey members,” said Jamie Reynoso, CEO of Medicare Advantage at Clover Health. “By working with the pharmacists who are already embedded in our communities, we can deliver better care, deliver amazing customer experiences and support the independent businesses that keep New Jersey strong.” Participating iCare+ pharmacies will use real-time tools, powered by Clover Assistant data and AI models, to monitor prescription fills, identify adherence gaps, and collaborate with local doctors and Clover’s care teams. The goal: make it easier for seniors to get the right medications at the right time, while keeping their care close to home. “Clover Health understands that innovation doesn’t always mean centralization,” said Ashton Maaraba, President of IPC Digital Health. “This partnership helps New Jersey’s independent pharmacies lead the way in delivering smarter, more connected care.” This new program is part of Clover’s broader commitment to investing in New Jersey communities, by combining modern technology, local relationships, and a belief that healthcare should feel personal again. About Clover Health: Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence and Congestive Heart Failure, as well as the earlier identification and management of Diabetes and Chronic Kidney Disease. Visit: www.cloverhealth.com Investor Relations: Ryan Schmidt investors@cloverhealth.com Press Inquiries: press@cloverhealth.com About IPC Digital Health™IPC Digital Health™ is the innovation arm of the Independent Pharmacy Cooperative, the country’s largest GPO owned by independent pharmacies. Through its iCare+™ platform, IPC delivers digital health solutions that strengthen the clinical and financial future of community pharmacies. Learn more at www.myicareplus.com

Related News